Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular dissection of dystrophin identifies the docking site for nNOS.

Literature DB >> 23277550

Molecular dissection of dystrophin identifies the docking site for nNOS.

Scott Q Harper¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2012 PMID： 23277550 PMCID： PMC3545786 DOI： 10.1073/pnas.1220256110

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

16 in total

1. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.

Authors: S B England; L V Nicholson; M A Johnson; S M Forrest; D R Love; E E Zubrzycka-Gaarn; D E Bulman; J B Harris; K E Davies
Journal: Nature Date: 1990-01-11 Impact factor: 49.962

Review 2. Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.

Authors: T A Rando
Journal: Microsc Res Tech Date: 2001-11-15 Impact factor: 2.769

3. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.

Authors: Scott Q Harper; Michael A Hauser; Christiana DelloRusso; Dongsheng Duan; Robert W Crawford; Stephanie F Phelps; Hollie A Harper; Ann S Robinson; John F Engelhardt; Susan V Brooks; Jeffrey S Chamberlain
Journal: Nat Med Date: 2002-03 Impact factor: 53.440

4. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

Authors: J E Brenman; D S Chao; H Xia; K Aldape; D S Bredt
Journal: Cell Date: 1995-09-08 Impact factor: 41.582

5. Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable.

Authors: Scott Q Harper; Robert W Crawford; Christiana DelloRusso; Jeffrey S Chamberlain
Journal: Hum Mol Genet Date: 2002-08-01 Impact factor: 6.150

6. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors: M Koenig; A P Monaco; L M Kunkel
Journal: Cell Date: 1988-04-22 Impact factor: 41.582

7. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors: A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal: Nature Date: 1986 Oct 16-22 Impact factor: 49.962

8. α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding.

Authors: Yi Lai; Junling Zhao; Yongping Yue; Dongsheng Duan
Journal: Proc Natl Acad Sci U S A Date: 2012-11-26 Impact factor: 11.205

9. A new model for the interaction of dystrophin with F-actin.

Authors: I N Rybakova; K J Amann; J M Ervasti
Journal: J Cell Biol Date: 1996-11 Impact factor: 10.539

10. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.

Authors: Akihiro Asai; Nita Sahani; Masao Kaneki; Yasuyoshi Ouchi; J A Jeevendra Martyn; Shingo Egusa Yasuhara
Journal: PLoS One Date: 2007-08-29 Impact factor: 3.240

6 in total

6. A Genotype-Phenotype Correlation Study of Exon Skip-Equivalent In-Frame Deletions and Exon Skip-Amenable Out-of-Frame Deletions across the DMD Gene to Simulate the Effects of Exon-Skipping Therapies: A Meta-Analysis.

Authors: Saeed Anwar; Merry He; Kenji Rowel Q Lim; Rika Maruyama; Toshifumi Yokota
Journal: J Pers Med Date: 2021-01-14